First-Quarter 2011 Business Review

21 April, 2011

bioMérieux, a world leader in the field of in vitro diagnostics, today released its business review for the three months ended March 31, 2011. Net sales for the period reached €328 million, up a reported 6.8% from €307 million in first-quarter 2010. Growth amounted to 3.5% like-for-like (at constant exchange rates and scope of consolidation).

Sales growth: 3.5% like-for-like

  • Strong momentum in North America
  • Temporary slowdown in China and India
  • Robust growth in clinical microbiology
  • 2011 sales growth objective confirmed at 5% to 6%*

 

Pioneering Diagnostics